相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Additional L-Carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin
Kousuke Kubota et al.
DIGESTIVE DISEASES (2022)
Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function
Kunihiko Yokoyama et al.
PLOS ONE (2022)
Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study
Hideto Kawaratani et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
Yasuyuki Tamai et al.
JGH OPEN (2021)
Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy
Yudai Fujiwara et al.
INTERNAL MEDICINE (2021)
Reduced handgrip strength predicts poorer survival in chronic liver diseases: A large multicenter study in Japan
Hiroki Nishikawa et al.
HEPATOLOGY RESEARCH (2021)
Evidence-based clinical practice guidelines for liver cirrhosis 2020
Hitoshi Yoshiji et al.
HEPATOLOGY RESEARCH (2021)
Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis
Akira Sakamaki et al.
INTERNAL MEDICINE (2020)
Impaired brain function improved by l-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopy
Hiroyuki Nakanishi et al.
SCIENTIFIC REPORTS (2020)
Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients
Kosuke Kaji et al.
ANTIBIOTICS-BASEL (2020)
Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials
Takumi Kawaguchi et al.
HEPATOLOGY RESEARCH (2019)
Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese
Shinya Nishida et al.
WORLD JOURNAL OF HEPATOLOGY (2019)
Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trial
Kazuyuki Suzuki et al.
HEPATOLOGY RESEARCH (2018)
Cross-over study in hyperammonemia patients for efficacy, safety, and acceptability of a new lactulose preparation (SK-1202) compared to approved drug
Hitoshi Yoshiji et al.
HEPATOLOGY RESEARCH (2018)
Treatment for cirrhotic ascites
Hideto Kawaratani et al.
HEPATOLOGY RESEARCH (2017)
Carnitine dynamics and their effects on hyperammonemia in cirrhotic Japanese patients
Makoto Shiraki et al.
HEPATOLOGY RESEARCH (2017)
Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis
Tatsunori Hanai et al.
HEPATOLOGY RESEARCH (2017)
Branched-chain amino acids for people with hepatic encephalopathy
Lise Lotte Gluud et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver
Hendrik Vilstrup et al.
HEPATOLOGY (2014)
Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: Evaluation by near-infrared spectroscopy
Hiroyuki Nakanishi et al.
HEPATOLOGY RESEARCH (2014)
Alterations of the human gut microbiome in liver cirrhosis
Nan Qin et al.
NATURE (2014)
A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy
Barjesh Chander Sharma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Large-Scale Survey of Gut Microbiota Associated With MHE Via 16S rRNA-Based Pyrosequencing
Zhigang Zhang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Genta Kakiyama et al.
JOURNAL OF HEPATOLOGY (2013)
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo
Barjesh Chander Sharma et al.
GASTROENTEROLOGY (2009)
Hepatic encephalopathy
Santiago J. Munoz
MEDICAL CLINICS OF NORTH AMERICA (2008)
Review article: the burden of hepatic encephalopathy
F. F. Poordad
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Management of hepatic encephalopathy in patients with cirrhosis
Gavin Wright et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2007)
Effects of L-carnitine in patients with hepatic encephalopathy
Mariano Malaguarnera et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis
Y Muto et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Branched-chain amino acid treatment in patients with liver cirrhosis
K Suzuki et al.
HEPATOLOGY RESEARCH (2004)
分享论文
